REFERENCES:

Bastian LA et al. Women’s interest in chemoprevention for breast cancer. Arch Intern Med 2001;161:1639-44. Abstract

Brown PH, Lippman SM. Chemoprevention of breast cancer. Breast Cancer Res Treat 2000;62:1-17. Abstract

Cauley JA et al. Continued breast cancer risk reduction in postmenopausal women treated with raloxifene: 4-year results from the MORE trial. Multiple outcomes of raloxifene evaluation. Breast Cancer Res Treat 2001;65(2):125-34. Abstract

Chlebowski RT et al. American Society of Clinical Oncology technology assessment on breast cancer risk reduction strategies: Tamoxifen and raloxifene. J Clin Oncol 1999;17(6):1939-55. Abstract

Cuzick J. Future possibilities in the prevention of breast cancer: Breast cancer prevention trials. Breast Cancer Res 2000;2:258-63. Abstract

Cy ru s - David MS, St rom SS. Chemoprevention of breast cancer with selective e s t rogen receptor modulators: Views from broadly diverse focus groups of women with elevated risk for breast cancer. Psychooncology 2001; 10:521-33. Abstract

Day R et al. Tamoxifen and depression: More evidence from the National Surgical Adjuvant Breast and Bowel Project’s Breast Cancer Prevention (P-1) Randomized Study. J Natl Cancer Inst 2001;93:1615-23. Abstract

Day R et al. Health-related quality of life and tamoxifen in breast cancer prevention: A report from the National Surgical Adjuvant Breast and Bowel Project P-1 Study. J Clin Oncol 1999;17(9):2659-69. Abstract

Eeles RA, Powles TJ. Chemoprevention options for BRCA1 and BRCA2 mutation carriers. J Clin Oncol 2000;18:93S-9S. Abstract

Fabian CJ. Breast cancer chemoprevention: Beyond tamoxifen. Breast Cancer Res 2001;3:99-103. Abstract

Fallowfield L et al. Tamoxifen for the prevention of breast cancer: Psychosocial impact on women participating in two randomized controlled trials. J Clin Oncol 2001;19:1885-92. Abstract

Fisher B et al. Tamoxifen for prevention of breast cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. J Natl Cancer Inst 1998;90(18):1371-88. Abstract

Gail MH et al. Weighing the risks and benefits of tamoxifen treatment for preventing breast cancer. J Natl Cancer Inst 1999;91(21):1829-1846. Abstract

Goss PE, Strasser K. Aromatase inhibitors in the treatment and prevention of breast cancer. J Clin Oncol 2001;19(3):881-94. Abstract

Hershman DL et al. Outcomes of tamoxifen chemoprevention for breast cancer in very high-risk women: A decision analysis. Proc ASCO 2001; Abstract 976.

Ingle JN. Aromatase inhibition and antiestrogen therapy in early breast cancer treatment and chemoprevention. Oncology (Huntingt) 2001;15:28-34. Abstract

Jordan VC et al. Selective estrogen receptor modulation and reduction in risk of breast cancer, osteoporosis, and coronary heart disease. J Natl Cancer Inst 2001;93(19):1449-1457. Abstract

Julian-Reynier CM et al. Women’s attitudes toward preventive strategies for hereditary breast or ovarian carcinoma differ from one country to another: Differences among English, French, and Canadian women. Cancer 2001;92:959-68. Abstract

Kopczak SD et al. Breast cancer risk assessment (RA) and prevention education: Changing perceptions of and emotional responses to risk in a community center for breast care. Proc ASCO 2001; Abstract 1892.

King MC et al. Tamoxifen and breast cancer incidence among women with inherited mutations in BRCA1 and BRCA2: National Surgical Adjuvant Breast and Bowel Project (NSABP-P1) Breast Cancer Prevention Trial. JAMA 2001;286(18):2251-6. Abstract

Lippman SM et al. Tamoxifen prevention of breast cancer: An instance of the fingerpost. J Natl Cancer Inst 1999;91(21):1809-1819. Abstract

Minton SE. Chemoprevention of breast cancer in the older patient. Hematol Oncol Clin North Am 2000;14:113-30. Abstract

O’Reagan RM, Jordan VC. Tamoxifen to raloxifene and beyond. Semin Oncol 2001;28(3):260-73. Abstract

Powles T et al. Interim analysis of the incidence of breast cancer in the Royal Marsden Hospital tamoxifen randomised chemoprevention trial. Lancet 1998;352:98-101. Abstract

Rockhill B, et al. Validation of the Gail et al. model of breast cancer risk prediction and implications for chemoprevention. J Natl Cancer Inst 2001;93:358-66. Abstract

Wickerham DL, Tan-Chiu E. Breast cancer chemoprevention: Current status and future directions. Semin Oncol 2001;28:253-9. Abstract

Back | Top of Page